Guideline-directed medical therapy after transcatheter edge-to-edge mitral valve repair.
Tetsu TenakaRefik KavsurMaximilian SpiekerChristos IliadisClemens MetzeBirthe M BrachtendorfPatrick HornChristian ZachovalAtsushi SugiuraMalte KelmStephan BaldusGeorg NickenigRalf WestenfeldRoman PfisterMarc Ulrich BecherPublished in: Heart (British Cardiac Society) (2022)
GDMT, defined as triple therapy consisting of beta-blockers, RAS inhibitors and MRAs, was associated with a reduced risk of 2-year mortality after TEER for SMR. Optimisation of medical therapy is crucial to improve clinical outcomes in patients undergoing TEER for SMR.